home All News open_in_new Full Article

Pharmaindustrie: Leberschäden in Studie – Pfizer beendet Entwicklung von Diätmittel

Der US-Pharmakonzern muss einen weiteren Rückschlag hinnehmen und stellt die Forschung an einer Abnehmtablette ein. Damit gerät Pfizer-Chef Albert Bourla weiter unter Druck.


today 31 h. ago attach_file Society

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Society
attach_file Politics
attach_file Politics
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Politics
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society


ID: 2412897431
Add Watch Country

arrow_drop_down